Atherosclerosis

Atherosclerosis · ISSN (print) 0021-9150 · 4 papers in corpus
2022
Non-genetic influences on lipoprotein(a) concentrations.
doi:10.1016/j.atherosclerosis.2022.04.006 ·PMID:35606076

An elevated level of lipoprotein(a) [Lp(a)] is a genetically regulated, independent, causal risk factor for cardiovascular disease. However, the extensive variability in Lp(a) levels between individuals and population groups cannot be fully…

article 2011
Increased asymmetric dimethylarginine and enhanced inflammation are associated with impaired vascular reactivity in women with endometriosis
doi:10.1016/j.atherosclerosis.2011.08.005 ·PMID:21880316

ObjectiveEnhanced inflammatory responses which may inhibit vascular reactivity, are associated with endometriosis development. Asymmetric dimethylarginine (ADMA), an inhibitor of endogenous nitric oxide synthase, is also implicated in endot…

article 1992
Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid
doi:10.1016/0021-9150(92)90008-5 ·PMID:1533522

Serum levels of lipids, lipoproteins and apolipoproteins were measured in 26 premenopausal women with endometriosis both before and after six months therapy with the anabolic steroid danazol (600 mg/day) and in 15 untreated women who acted …

article 1982
Effect of danazol on plasma lipid and lipoprotein levels in normal women
doi:10.1016/0021-9150(82)90105-8 ·PMID:7092979

Prior studies of lipid and lipoprotein levels alterations associated with the administration of danazol, a testosterone derivative, in patients treated for endometriosis have been conflicting. We administered danazol to 7 normal menstruatin…